Equity Overview
Price & Market Data
Price: $0.04
Daily Change: $0.00 / 0.00%
Daily Range: $0.0391 - $0.045
Market Cap: $844,106
Daily Volume: 964,913
Performance Metrics
1 Week: -16.67%
1 Month: %
3 Months: -45.95%
6 Months: -99.51%
1 Year: -99.99%
YTD: -43.66%
Details
CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead development candidate is CER-1236, an autologous T cell therapy candidate for the treatment of hematologic malignancies and solid tumors. The company was incorporated in 2021 and is based in South San Francisco, California.